1230118007: Product containing precisely bacitracin 250 unit/1 gram and neomycin sulfate 5 milligram/1 gram and sulfacetamide sodium 60 milligram/1 gram conventional release cutaneous powder (clinical drug)

• SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...
• \Product manufactured as cutaneous dose form\Neomycin-containing product in cutaneous dose form\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Product manufactured as cutaneous dose form\Bacitracin-containing product in cutaneous dose form\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Product manufactured as cutaneous dose form\Sulfacetamide-containing product in cutaneous dose form\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Medicinal product categorised by disposition\Bacitracin-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Medicinal product categorised by disposition\Bacitracin-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin and neomycin and sulfacetamide only product\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Medicinal product categorised by disposition\Bacitracin-containing product\Bacitracin-containing product in cutaneous dose form\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Medicinal product categorised by disposition\Neomycin-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Medicinal product categorised by disposition\Neomycin-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin and neomycin and sulfacetamide only product\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Medicinal product categorised by disposition\Neomycin-containing product\Neomycin-containing product in cutaneous dose form\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Medicinal product categorised by disposition\Sulfacetamide-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Medicinal product categorised by disposition\Sulfacetamide-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin and neomycin and sulfacetamide only product\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Medicinal product categorised by disposition\Sulfacetamide-containing product\Sulfacetamide-containing product in cutaneous dose form\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Peptide-containing product\Cyclic peptide-containing product\Bacitracin-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Peptide-containing product\Cyclic peptide-containing product\Bacitracin-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin and neomycin and sulfacetamide only product\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Peptide-containing product\Cyclic peptide-containing product\Bacitracin-containing product\Bacitracin-containing product in cutaneous dose form\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Sulfonamide-containing product\Sulfonamide antibacterial agent\Sulfacetamide-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Sulfonamide-containing product\Sulfonamide antibacterial agent\Sulfacetamide-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin and neomycin and sulfacetamide only product\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Sulfonamide-containing product\Sulfonamide antibacterial agent\Sulfacetamide-containing product\Sulfacetamide-containing product in cutaneous dose form\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Medicinal product categorised by structure\Sulfur and/or sulfur compound-containing product\Sulfonamide-containing product\Sulfonamide antibacterial agent\Sulfacetamide-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Medicinal product categorised by structure\Sulfur and/or sulfur compound-containing product\Sulfonamide-containing product\Sulfonamide antibacterial agent\Sulfacetamide-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin and neomycin and sulfacetamide only product\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Medicinal product categorised by structure\Sulfur and/or sulfur compound-containing product\Sulfonamide-containing product\Sulfonamide antibacterial agent\Sulfacetamide-containing product\Sulfacetamide-containing product in cutaneous dose form\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Medicinal product categorised by structure\Glycoside-containing product\Aminoglycoside-containing product\Aminoglycoside antibacterial agent\Neomycin-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Medicinal product categorised by structure\Glycoside-containing product\Aminoglycoside-containing product\Aminoglycoside antibacterial agent\Neomycin-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin and neomycin and sulfacetamide only product\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Medicinal product categorised by structure\Glycoside-containing product\Aminoglycoside-containing product\Aminoglycoside antibacterial agent\Neomycin-containing product\Neomycin-containing product in cutaneous dose form\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Medicinal product categorised by therapeutic role\Antiinfective agent\Antibacterial agent\...
• \Aminoglycoside antibacterial agent\Neomycin-containing product\...
• \Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin and neomycin and sulfacetamide only product\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Neomycin-containing product in cutaneous dose form\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Bacitracin-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Bacitracin-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin and neomycin and sulfacetamide only product\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Bacitracin-containing product\Bacitracin-containing product in cutaneous dose form\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Sulfonamide antibacterial agent\Sulfacetamide-containing product\...
• \Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin and neomycin and sulfacetamide only product\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
• \Sulfacetamide-containing product in cutaneous dose form\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder

Status: current, Defined. Date: 30-Jun 2022. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
5067244011	Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder	en	Synonym	Active	Case insensitive	SNOMED CT core
5067245012	Product containing precisely bacitracin 250 unit/1 gram and neomycin sulfate 5 milligram/1 gram and sulfacetamide sodium 60 milligram/1 gram conventional release cutaneous powder (clinical drug)	en	Fully specified name	Active	Case insensitive	SNOMED CT core

Expanded Value Set

This concept is not in any reference sets

Back to Start